Thrivent Financial For Lutherans Charles River Laboratories International, Inc. Transaction History

Thrivent Financial For Lutherans

  • $45.7 Billion
  • Q2 2025

A detailed history of Thrivent Financial For Lutherans transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 22,176 shares of CRL stock, worth $3.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,176
Previous 2,004 1006.59%
Holding current value
$3.79 Million
Previous $302,000 1014.24%
% of portfolio
0.01%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 26, 2025
BUY
$99.75 - $151.89 $2.01 Million - $3.06 Million
20,172 Added 1006.59%
22,176 $3.37 Million
Q1 2025

Aug 26, 2025
BUY
$150.52 - $190.14 $301,642 - $381,040
2,004 New
2,004 $302,000
Q4 2024

Feb 10, 2025
SELL
$178.58 - $220.69 $58.4 Million - $72.2 Million
-327,239 Reduced 98.37%
5,423 $1 Million
Q3 2024

Nov 07, 2024
SELL
$187.96 - $245.29 $7.89 Million - $10.3 Million
-41,997 Reduced 11.21%
332,662 $65.5 Million
Q2 2024

Aug 13, 2024
SELL
$206.39 - $268.73 $39.5 Million - $51.4 Million
-191,205 Reduced 33.79%
374,659 $77.4 Million
Q1 2024

May 14, 2024
BUY
$203.52 - $273.43 $25 Million - $33.6 Million
123,065 Added 27.79%
565,864 $153 Million
Q4 2023

Feb 14, 2024
BUY
$164.52 - $238.84 $67.2 Million - $97.6 Million
408,643 Added 1196.4%
442,799 $105 Million
Q3 2023

Nov 14, 2023
SELL
$194.44 - $217.61 $1,555 - $1,740
-8 Reduced 0.02%
34,156 $6.69 Million
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $5.88 Million - $6.72 Million
31,980 Added 1464.29%
34,164 $7.18 Million
Q1 2023

May 17, 2023
SELL
$191.89 - $259.92 $4.05 Million - $5.48 Million
-21,095 Reduced 90.62%
2,184 $441,000
Q4 2022

Feb 08, 2023
SELL
$197.11 - $250.07 $11.9 Million - $15.1 Million
-60,288 Reduced 72.14%
23,279 $5.07 Million
Q3 2022

Nov 14, 2022
BUY
$182.44 - $250.54 $4.09 Million - $5.61 Million
22,411 Added 36.65%
83,567 $16.4 Million
Q2 2022

Aug 16, 2022
BUY
$204.13 - $302.4 $2.31 Million - $3.42 Million
11,318 Added 22.71%
61,156 $13.1 Million
Q1 2022

May 13, 2022
SELL
$255.51 - $362.11 $9.94 Million - $14.1 Million
-38,917 Reduced 43.85%
49,838 $14.2 Million
Q4 2021

Feb 16, 2022
BUY
$351.38 - $448.68 $12.9 Million - $16.5 Million
36,769 Added 70.73%
88,755 $33.4 Million
Q3 2021

Nov 15, 2021
BUY
$372.64 - $458.3 $72,292 - $88,910
194 Added 0.37%
51,986 $21.5 Million
Q2 2021

Aug 19, 2021
SELL
$294.17 - $371.65 $3.21 Million - $4.05 Million
-10,907 Reduced 17.4%
51,792 $19.2 Million
Q1 2021

May 17, 2021
SELL
$249.67 - $299.48 $869,350 - $1.04 Million
-3,482 Reduced 5.26%
62,699 $18.2 Million
Q4 2020

Feb 16, 2021
SELL
$222.0 - $252.62 $24,642 - $28,040
-111 Reduced 0.17%
66,181 $16.5 Million
Q3 2020

Nov 10, 2020
SELL
$175.56 - $226.45 $772,464 - $996,380
-4,400 Reduced 6.22%
66,292 $15 Million
Q2 2020

Aug 12, 2020
SELL
$118.84 - $189.72 $1.98 Million - $3.17 Million
-16,697 Reduced 19.11%
70,692 $12.3 Million
Q1 2020

May 15, 2020
SELL
$98.9 - $178.34 $7.85 Million - $14.2 Million
-79,413 Reduced 47.61%
87,389 $11 Million
Q4 2019

Feb 13, 2020
BUY
$126.05 - $152.76 $9.69 Million - $11.7 Million
76,880 Added 85.5%
166,802 $25.5 Million
Q3 2019

Nov 14, 2019
SELL
$125.07 - $143.67 $450,001 - $516,924
-3,598 Reduced 3.85%
89,922 $11.9 Million
Q2 2019

Aug 13, 2019
BUY
$123.4 - $148.55 $54,296 - $65,362
440 Added 0.47%
93,520 $13.3 Million
Q1 2019

May 14, 2019
BUY
$104.82 - $146.73 $27,672 - $38,736
264 Added 0.28%
93,080 $13.5 Million
Q4 2018

Feb 15, 2019
BUY
$105.09 - $137.23 $68,203 - $89,062
649 Added 0.7%
92,816 $10.5 Million
Q3 2018

Nov 15, 2018
BUY
$112.11 - $134.54 $9.11 Million - $10.9 Million
81,250 Added 744.25%
92,167 $12.4 Million
Q2 2018

Aug 14, 2018
SELL
$102.37 - $117.25 $17,710 - $20,284
-173 Reduced 1.56%
10,917 $1.23 Million
Q1 2018

May 08, 2018
BUY
$98.19 - $115.2 $74,133 - $86,976
755 Added 7.31%
11,090 $1.18 Million
Q4 2017

Feb 14, 2018
BUY
$100.43 - $118.09 $17,575 - $20,665
175 Added 1.72%
10,335 $1.13 Million
Q3 2017

Nov 14, 2017
BUY
$96.72 - $109.26 $982,675 - $1.11 Million
10,160
10,160 $1.1 Million

Others Institutions Holding CRL

# of Institutions
619
Shares Held
52.7M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.68B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email